was successfully added to your cart.

Your SEO optimized title page contents

Michael Mayes Interview on WGN at Northern Illinois Town Hall

On Aug. 20, hundreds of people gathered at Northern Illinois’ Town Hall meeting to learn more about the upcoming application process for patients, caregivers, dispensaries and cultivation centers.

Quantum 9 CEO Michael Mayes was interviewed by WGN for a segment on the event.

While the event was designed to answer questions primarily about the patient and caregiver application period that starts Sept. 1, a vast majority of the questions surrounded dispensary and cultivation center applications. There are a limited number of licenses available for these entities, and in order to secure one Mayes said “it will not only require luck, but also skill, so they’re looking for operators who have a tremendous amount of experience, not only in horticulture, but retail as well.

Mayes also commented on the patient and caregiver applications, expressing concern for the stringent requirements.

“Currently it’s required that all patients have a criminal background check, a 12-month bonafide relationship with a physician, as well as fingerprinting,” said Mayes. “With those restrictions, it makes it incredibly difficult for a patient, especially with a debilitating illness, to obtain a card.”


About Michael Mayes

As Chief Executive Officer for Quantum 9, Inc., Michael has assisted in funding some of the largest commercial cannabis projects in the world. Michael has been a cannabis investor since 2009 in Colorado’s first legal for-profit cannabis market. As the co-founder and CEO of Quantum 9, Inc., Michael has spent years designing technology and collaborating with countless consultants on the forefront of the cannabis industry. Collaborating with the brightest minds and contributing to world-class organizations has been an incredibly enlightening and rewarding experience for him. Also, he has amassed a comprehensive and award-winning team engaged globally for public policy best practices through the prioritization of environmental sustainability and patient care. Michael is a member of the International Cannabinoid Research Society (ICRS), contributor to Marijuana Business Daily, quoted in the Chicago Tribune, Tampa Tribune, Yahoo Finance, Tampa Tribune, Sativa Magazine, CBC and the Daily Herald. His media appearances include several CBS and WGN appearances and international presence on BNN Commodities in Canada. On the public policy front, Michael and his team were instrumental in their work of drafting the Kentucky Medical Marijuana Bill for Senator Perry Clark. Most recently, Michael taught a class for the International Pharmaceutical Academy in Toronto, Canada. He spoke on Cannabis Pharmacology, and the effects cannabis has on the endocannabinoid system.

Leave a Reply